🔥🐔 BizChicken 🐔🔥

Companies Similar to ZyVersa Therapeutics, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

KVD001, sebetralstat, KVD824, Factor XIIa

Kal Vista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing small molecule protease inhibitors for diseases with unmet needs, including hereditary angioedema and diabetic macular edema.

Tags: Clinical Trials, Diabetic Macular Edema, Hereditary Angioedema, Pharmaceuticals, Protease Inhibitors

Symbol: KALV

Recent Price: $8.39

Industry: Biotechnology

CEO: Mr. Benjamin L. Palleiko

Sector: Healthcare

Employees: 150

Address: 55 Cambridge Parkway, Cambridge, MA 02142

Phone: 857 999 0075

Leadership

  • Albert Cha, Member of Board of Directors
  • William (Bill) Fairey, Member of Board of Directors
  • Benjamin L. Palleiko, Chief Executive Officer and Director
  • Brian J. G. Pereira, Member of Board of Directors
  • Nancy Stuart, Member of Board of Directors
  • Pat Treanor, Member of Board of Directors
  • Edward W. Unkart, Member of Board of Directors

Last updated: 2024-12-31

NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ZYESAMI, NRX-100, NRX-101

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

Tags: CNS disorders, COVID-19 treatment, bipolar depression, clinical-stage pharmaceutical, pulmonary diseases, suicidal behavior

Symbol: NRXP

Recent Price: $1.53

Industry: Biotechnology

CEO: Dr. Jonathan C. Javitt M.D., M.P.H.

Sector: Healthcare

Employees: 2

Address: 1201 Orange Street, Wilmington, DE 19801

Phone: 484 254 6134

Last updated: 2024-12-31

Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

zilovertamab, ONCT-216, ONCT-808, ONCT-534

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.

Tags: CAR-T, ROR1, antibody, biopharmaceutical, cancer therapy, clinical-stage, oncology

Symbol: ONCT

Recent Price: $0.53

Industry: Biotechnology

CEO: Dr. James B. Breitmeyer M.D., Ph.D.

Sector: Healthcare

Employees: 27

Address: 12230 El Camino Real, San Diego, CA 92130

Phone: 858 434 1113

Last updated: 2024-12-31

Vera Therapeutics, Inc.

Vera Therapeutics, Inc. logo
Market Cap: High
Employees: Low

atacicept

Vera Therapeutics, Inc. is a clinical stage biotechnology company focusing on developing and commercializing treatments for serious immunological diseases, including atacicept for immunoglobulin A nephropathy and MAU868 for BK viremia infections.

Tags: MAU868, atacicept, biotechnology, clinical trial, immunological diseases

Symbol: VERA

Recent Price: $42.06

Industry: Biotechnology

CEO: Dr. Marshall W. Fordyce M.D.

Sector: Healthcare

Employees: 72

Address: 8000 Marina Boulevard, Brisbane, CA 94005

Phone: 650 770 0077

Last updated: 2024-12-31

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Zunsemetinib

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.

Tags: atopic dermatitis, autoimmune diseases, biopharmaceutical, cancer, contract research, drug development, immune-inflammatory diseases, psoriatic arthritis, rheumatoid arthritis, therapeutics

Symbol: ACRS

Recent Price: $2.48

Industry: Medical - Diagnostics & Research

CEO: Dr. Neal S. Walker D.O., M.D.

Sector: Healthcare

Employees: 86

Address: 640 Lee Road, Wayne, PA 19087

Phone: 484 324 7933

Last updated: 2024-12-31

Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan

Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.

Tags: ADHD, ALS, biotechnology, neurology, opioid dependence, oral soluble film, pharmaceutical

Symbol: AQST

Recent Price: $3.52

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Daniel Barber

Sector: Healthcare

Employees: 135

Address: 30 Technology Drive, Warren, NJ 07059

Phone: 908 941 1900

Last updated: 2024-12-31

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

STAR-0215

Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.

Tags: allergic diseases, biopharmaceutical, hereditary angioedema, immunological diseases, rare diseases

Symbol: ATXS

Recent Price: $8.88

Industry: Biotechnology

CEO: Ms. Jill C. Milne Ph.D.

Sector: Healthcare

Employees: 59

Address: 100 High Street, Boston, MA 02110

Phone: 617 349 1971

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Erasca, Inc.

Erasca, Inc. logo
Market Cap: Medium
Employees: Low

ERAS-007, ERAS-601, ERAS-801

Erasca, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Tags: ERAS-007, ERAS-601, ERAS-801, RAS/MAPK, biopharmaceutical, cancers

Symbol: ERAS

Recent Price: $2.55

Industry: Biotechnology

CEO: Dr. Jonathan E. Lim M.D.

Sector: Healthcare

Employees: 126

Address: 10835 Road to the Cure, San Diego, CA 92121

Phone: 858 465 6511

Last updated: 2024-12-31

Kintara Therapeutics, Inc.

Kintara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

VAL-083, REM-001

Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.

Tags: REM-001, VAL-083, anti-cancer therapies, clinical stage, drug development

Symbol: KTRA

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.

Sector: Healthcare

Employees: 1

Address: 12707 High Bluff Drive, San Diego, CA 92130

Phone: 858 350 4364

Leadership

  • Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
  • Greg A. Johnson, (Acting) Head of Operations
  • Laura Johnson, Director
  • Tamara A. Favorito, Director
  • Robert J. Toth, Jr., M.B.A., Director

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Verve Therapeutics, Inc.

Verve Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

VERVE-101

Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.

Tags: VERVE-101, biotechnology, cardiovascular diseases, gene editing, genetic medicines

Symbol: VERV

Recent Price: $5.54

Industry: Biotechnology

CEO: Dr. Sekar Kathiresan M.D.

Sector: Healthcare

Employees: 255

Address: 500 Technology Square, Cambridge, MA 02139

Phone: 617 603 0070

Leadership

  • Andrew Ashe, President, Chief Operating Officer and General Counsel
  • Victoria Bartlett, Vice President, Program and Alliance Management
  • Dan Balian, Associate Director, Supply Chain Management
  • Allen Barrett, Director, Corporate Counsel

Last updated: 2024-12-31

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

VP-102, VP-103

Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.

Tags: dermatology, molluscum contagiosum, oncology, pharmaceuticals, skin diseases, warts

Symbol: VRCA

Recent Price: $0.70

Industry: Biotechnology

CEO: Mr. Ted White

Sector: Healthcare

Employees: 100

Address: 44 West Gay Street, West Chester, PA 19380

Phone: 484 453 3300

Last updated: 2024-12-31

Verastem, Inc.

Verastem, Inc. logo
Market Cap: Low
Employees: Low

VS-6766

Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.

Tags: MEK, RAF, RAMP 201, RAMP 202, VS-6766, biopharmaceutical, cancer treatment, drug development

Symbol: VSTM

Recent Price: $3.67

Industry: Biotechnology

CEO: Mr. Daniel W. Paterson

Sector: Healthcare

Employees: 73

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 781 292 4200

Last updated: 2024-12-31

VYNE Therapeutics Inc.

VYNE Therapeutics Inc. logo
Market Cap: Lowest
Employees: Lowest

FCD105, FMX114, VYN201, VYN202

VYNE Therapeutics Inc. is a pharmaceutical company specializing in developing therapeutics for immuno-inflammatory conditions. Key products include FCD105 for acne vulgaris, FMX114 for atopic dermatitis, and BET inhibitors VYN201 and VYN202 for skin and other immuno-inflammatory diseases.

Tags: BET inhibitors, acne vulgaris, atopic dermatitis, immuno-inflammatory, pharmaceutical, therapeutics

Symbol: VYNE

Recent Price: $3.19

Industry: Biotechnology

CEO: Mr. David T. Domzalski

Sector: Healthcare

Employees: 10

Address: 520 U.S. Highway 22, Bridgewater, NJ 08807

Phone: 800 775 7936

Last updated: 2024-12-31

Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

KP1077, KP879

Zevra Therapeutics is a rare disease company focused on developing proprietary prodrugs using Ligand Activated Therapy to treat medical conditions such as ADHD, stimulant use disorder, and CNS rare diseases. Their lead candidates include KP1077 for idiopathic hypersomnia and KP879 for stimulant use disorder.

Tags: CNS diseases, idiopathic hypersomnia, narcolepsy, prodrugs, rare disease, stimulant use disorder

Symbol: ZVRA

Recent Price: $8.21

Industry: Biotechnology

CEO: Mr. Neil F. McFarlane

Sector: Healthcare

Employees: 65

Address: 1180 Celebration Boulevard, Celebration, FL 34747

Phone: 321 939 3416

Last updated: 2024-12-31

ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

VAR 200 and IC 100

Zy Versa Therapeutics, Inc. is a clinical stage biopharmaceutical company developing products for renal and inflammatory diseases, including VAR 200 for focal segmental glomerulosclerosis and related conditions, and IC 100 as an ASC inhibitor for inflammatory diseases.

Tags: biopharmaceutical, cholesterol efflux mediator, inflammasome ASC inhibitor, inflammatory diseases, renal diseases

Symbol: ZVSA

Recent Price: $1.07

Industry: Biotechnology

CEO: Mr. Stephen C. Glover

Sector: Healthcare

Employees: 7

Address: 2200 N. Commerce Parkway, Weston, FL 33326

Phone: 754 231 1688

Leadership

  • Stephen C. Glover, Chairman of the Board at Ambrx Biopharma
  • Pablo A. Guzman, MD, FACC, Board of Directors member
  • Karen Cashmere, Board of Directors member
  • Peter Wolfe, Board of Directors member
  • Robert (Rob) G. Finizio, Executive Director of PleoPharma
  • GREGORY G. FREITAG, JD, CPA, Principal of FreiMc
  • Minchul Park, Ph.D, Chief Executive Officer, and Director of Curebio Therapeutics, Adjunct Professor, Korea University, Department of Pharmacy
  • JAMES SAPIRSTEIN, Chairman, Chief Executive Officer and President of First Wave Biopharma
  • N/A, N/A

Last updated: 2024-12-31

Theriva Biologics, Inc.

Theriva Biologics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SYN-004, SYN-020, VCN-01

Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.

Tags: biologics, biopharmaceutical, clinical-stage, disease treatment, microbiome, therapeutics

Symbol: TOVX

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Steven A. Shallcross CPA

Sector: Healthcare

Employees: 22

Address: 9605 Medical Center Drive, Rockville, MD 20850

Phone: 301 417 4364

Last updated: 2024-12-31

Virios Therapeutics, Inc.

Virios Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMC-1

Virios Therapeutics, Inc. is a biotechnology company focused on developing antiviral therapies for diseases associated with a viral triggered abnormal immune response, including fibromyalgia and long COVID.

Tags: IMC-1, IMC-2, antiviral therapies, biotechnology, fibromyalgia, long COVID

Symbol: VIRI

Recent Price: $0.15

Industry: Biotechnology

CEO: Mr. Gregory Duncan

Sector: Healthcare

Employees: 4

Address: 44 Milton Avenue, Alpharetta, GA 30009

Phone: 866 620 8655

Last updated: 2024-12-31

Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc. logo
Market Cap: Low
Employees: Low

VTX958

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.

Tags: VTX002, VTX2735, VTX958, autoimmune disorders, biopharmaceutical, clinical trials, inflammatory diseases, small molecule

Symbol: VTYX

Recent Price: $2.23

Industry: Biotechnology

CEO: Dr. Raju S. Mohan Ph.D.

Sector: Healthcare

Employees: 73

Address: 662 Encinitas Boulevard, Encinitas, CA 92024

Phone: 760 593 4832

Last updated: 2024-12-31